Individual provider · Type 1 NPI
Megan Seddon, PharmD
Infectious Diseases Pharmacist · Sarasota, FL
NPI number
1801649926
Active
Practice location
1700 S Tamiami Trl
Sarasota, FL 34239-3509
Mailing address
1333 Burgos Dr
Sarasota, FL 34238-2703
Specialties and licenses
| Taxonomy | Code | License |
|---|---|---|
| Infectious Diseases Pharmacist Primary | 1835I0206X | PS54909 (FL) |
Infectious Diseases Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in the use of microbiology and pharmacology to develop, implement, and monitor drug regimens that incorporate antimicrobials to optimize therapy for patients.
617 other providers at this address
- Bayview Surgical Services, Inc.Surgical Assistant Sarasota, FL NPI 1942447685
- Community Healthcare Practices LLCHospitalist Physician Sarasota, FL NPI 1164933032
- Community Hospitalists of FloridaHospitalist Physician Sarasota, FL NPI 1710405451
- Early StepsEarly Intervention Provider Agency Sarasota, FL NPI 1902085509
- Emergency & Acute Care Company - Southeast, LLCEmergency Medicine Physician Sarasota, FL NPI 1669423307
- Fitzgerald Surgical, PLLCSurgery Physician Sarasota, FL NPI 1396250965
- Global Physician Network LLC Series IEmergency Medicine Physician Sarasota, FL NPI 1316467525
- Imminent Surgical Associates PASurgery Physician Sarasota, FL NPI 1316338551
- Karmon Sears Psyd LLCClinical Psychologist Sarasota, FL NPI 1649565995
- Kirk G Voelker MD PAPulmonary Disease Physician Sarasota, FL NPI 1851356091
- Neuroscience Collaborative, LLCHealth Service Clinic/Center Sarasota, FL NPI 1366133506
- Panel of Electrocardiology of Sarasota Memorial HospitalCardiovascular Disease Physician Sarasota, FL NPI 1013967843
Other infectious diseases pharmacist providers in Sarasota
About NPI 1801649926
Megan Seddon, PharmD's National Provider Identifier is 1801649926, issued on Apr 9, 2024. The primary taxonomy on file is Infectious Diseases Pharmacist (1835I0206X), and the practice location is in Sarasota, FL. The record was last updated on Apr 9, 2024.